Quick Summary — GSBD scores higher on quality with 6.7/10 vs GRX's 1.8/10. GRX trades at $8.94 while GSBD trades at $9.14. Both analyzed daily using SEC EDGAR data across 13 institutional models.
GSBD scores higher with a 6.7/10 quality rating vs GRX's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $8.94, GRX trades +74.0% above its Bayesian DCF fair value of $2.33, while GSBD at $9.14 trades +33.6% above its estimate of $6.07. GRX shows a wider gap between price and intrinsic value.
GRX earns a Quality of Company score of 1.8/10 compared to GSBD's 6.7/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
Review the value trap analysis for both GRX and GSBD to assess whether apparent undervaluation reflects genuine opportunity or hidden fundamental risk.
Both GRX and GSBD operate in Asset Management, which has 448 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare GRX vs GSBD differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.